Related Experiment Video
Updated: Mar 19, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic
Nicholas W Van Hise1, Alex M Bryant2, Erin K Hennessey3
1Department of Pharmacy, Edward-Elmhurst Hospitals, Naperville, Illinois.
Abstract:
We compared rates of recurrent Clostridium difficile infection in patients receiving or not receiving oral vancomycin prophylaxis with systemic antimicrobial therapy. The incidence of C. difficile infection was significantly lower in patients receiving prophylaxis (4.2% vs 26.6% in those without prophylaxis; odds ratio, 0.12; 95% confidence interval, .04-.4; P < .001).
Related Concept Videos
Antimicrobial Effectiveness
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Clinical Significance of Antibiotic Resistance
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

